Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

Healthcare Medical Devices
MedMira Inc. is a Canada-based biotechnology company. The Company, through its subsidiaries, is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. The Company invests in research in order to maintain and expand its position in the global diagnostics market. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. The Company is the developer and owner of Rapid Vertical Flow (RVF) Technology. The Company's rapid test applications built on RVF Technology provide hospitals, labs, clinics and individuals with instant diagnosis for diseases such as Human Immunodeficiency Virus (HIV), Syphilis and hepatitis C in just three easy steps. The Company's tests are sold under the Reveal, Multiplo and Miriad brands in global markets. The Company's manufacturing facilities are located in Halifax, Nova Scotia, Canada.


TSXV:MIR - Post by User

MedMira Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(2638)
•••
Post by EtheGreaton Jul 08, 2020 9:55pm
234 Views
Post# 31243037

Possibility#2 ? - REVEALCOVID-19 + Vaccine(s) = Immunity Pro

Possibility#2 ? - REVEALCOVID-19 + Vaccine(s) = Immunity ProPossibility#2 ? - REVEALCOVID-19 + Vaccine(s) = Immunity Protection Assurances ? 

'jjwilson' i agree with U 100% REVEALCOVID-19 is not Antigen Test it is Total Test of any Variation including any new Strains this upcoming FLU season (Starts in USA Sept'20) 

Vaccines - here's what we know:  Small dosage of VIrus/Bacteria is given to person, and only Total Test that can be used to detect after vaccination is REVEALCOVID-19 !  REGARDLESS NO MATTER WHAT VACCINE is DEVELOPED ANYWHERE GLOBALLY !

Throughout History VACCINES (of which your body learns to develop resistance) has worked for the Human Race and is the defacto standard in survival against Bacteria/Viruses !

REVEALCOVID-19 will provide Immunity Protection Assurance !  Only Questions left are: duration & strength of protection...

So IMHO "No Rejection = Approval" ! at this junctionure in time & reaffirmed by Markus testament to Large Scale Production taking place right now !

What Else do Folks/PPL here need to know regarding Approval ?   REVEALCOVID-19 is/has already been Approved ?   EtheGreat or Not?

 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities